The incidence of gastric cancer is increasing year by year. Most gastric cancers are already
in the advanced stage with poor prognosis when diagnosed, which means the current …

Conventional detection of cancer involves highly invasive and expensive diagnostic
procedures, often leading to non-compliance from patients. Therefore, there is a strong …

Gastric cancer is the most commonly occurring cancer with a rapidly increasing incidence
rate worldwide. The underlying molecular mechanisms of gastric cancer require further …

Nowadays, the current bioinformatic methods have been increasingly applied in the field of
oncological research. In this study, we expect a better understanding of the molecular …

Purpose: To evaluate diagnostic and predictive values of the serum vascular endothelial
growth factor-A (VEGF-A) level and systemic immune-inflammation index (SII) in small cell …

Background The search of useful serum biomarkers for the early detection of cervical
cancers has been of a high priority. The activation of Macrophage-Colony Stimulating Factor …

Background Gastric cancer (GC) is the fourth most frequently diagnosed malignancy and the
second leading cause of cancer-associated mortality worldwide. The tumor …

Growth factors represent a family of important biological molecules that can also be critical in
the pathogenesis of various gastrointestinal cancers. In this study, we conducted a …

The clinical significance of plasma soluble programmed cell death ligand 1 (sPD-L1) and
vascular endothelial growth factor (VEGF) for non-small cell lung cancer (NSCLC) treated …

Objectives Gastric cancer ranks the fourth most common cancer and the third leading cause
of cancer mortality in the world. ROS proto-oncogene 1 (ROS1) is an oncogene and ROS1 …